An Open Access Database of Licensed Cancer Drugs
A global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for sup...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.627574/full |
id |
doaj-86a2ecc5b4d547199735cd3630fa58de |
---|---|
record_format |
Article |
spelling |
doaj-86a2ecc5b4d547199735cd3630fa58de2021-03-11T08:59:03ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-03-011210.3389/fphar.2021.627574627574An Open Access Database of Licensed Cancer DrugsPan Pantziarka0Pan Pantziarka1Rica Capistrano I2Arno De Potter3Liese Vandeborne4Gauthier Bouche5The Anticancer Fund, Brussels, BelgiumThe George Pantziarka TP53 Trust, London, United KingdomThe Anticancer Fund, Brussels, BelgiumFaculty of Medicine, University of Leuven, Leuven, BelgiumThe Anticancer Fund, Brussels, BelgiumThe Anticancer Fund, Brussels, BelgiumA global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for supportive care, diagnostic or other non-antineoplastic uses. We describe a methodology to combine and cleanse relevant data from multiple sources to produce an open access database of drugs licensed specifically for therapeutic antineoplastic purposes. The resulting list is provided as an open access database, (http://www.redo-project.org/cancer-drugs-db/), so that it may be used by researchers as input for further research projects, for example literature-based text mining for drug repurposing.https://www.frontiersin.org/articles/10.3389/fphar.2021.627574/fulldrug repurposingdrug licensingantineoplastic drugslicensed drugsdatabaselist of cancer drugs |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pan Pantziarka Pan Pantziarka Rica Capistrano I Arno De Potter Liese Vandeborne Gauthier Bouche |
spellingShingle |
Pan Pantziarka Pan Pantziarka Rica Capistrano I Arno De Potter Liese Vandeborne Gauthier Bouche An Open Access Database of Licensed Cancer Drugs Frontiers in Pharmacology drug repurposing drug licensing antineoplastic drugs licensed drugs database list of cancer drugs |
author_facet |
Pan Pantziarka Pan Pantziarka Rica Capistrano I Arno De Potter Liese Vandeborne Gauthier Bouche |
author_sort |
Pan Pantziarka |
title |
An Open Access Database of Licensed Cancer Drugs |
title_short |
An Open Access Database of Licensed Cancer Drugs |
title_full |
An Open Access Database of Licensed Cancer Drugs |
title_fullStr |
An Open Access Database of Licensed Cancer Drugs |
title_full_unstemmed |
An Open Access Database of Licensed Cancer Drugs |
title_sort |
open access database of licensed cancer drugs |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2021-03-01 |
description |
A global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for supportive care, diagnostic or other non-antineoplastic uses. We describe a methodology to combine and cleanse relevant data from multiple sources to produce an open access database of drugs licensed specifically for therapeutic antineoplastic purposes. The resulting list is provided as an open access database, (http://www.redo-project.org/cancer-drugs-db/), so that it may be used by researchers as input for further research projects, for example literature-based text mining for drug repurposing. |
topic |
drug repurposing drug licensing antineoplastic drugs licensed drugs database list of cancer drugs |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2021.627574/full |
work_keys_str_mv |
AT panpantziarka anopenaccessdatabaseoflicensedcancerdrugs AT panpantziarka anopenaccessdatabaseoflicensedcancerdrugs AT ricacapistranoi anopenaccessdatabaseoflicensedcancerdrugs AT arnodepotter anopenaccessdatabaseoflicensedcancerdrugs AT liesevandeborne anopenaccessdatabaseoflicensedcancerdrugs AT gauthierbouche anopenaccessdatabaseoflicensedcancerdrugs AT panpantziarka openaccessdatabaseoflicensedcancerdrugs AT panpantziarka openaccessdatabaseoflicensedcancerdrugs AT ricacapistranoi openaccessdatabaseoflicensedcancerdrugs AT arnodepotter openaccessdatabaseoflicensedcancerdrugs AT liesevandeborne openaccessdatabaseoflicensedcancerdrugs AT gauthierbouche openaccessdatabaseoflicensedcancerdrugs |
_version_ |
1724225825371324416 |